Royal Bank of Canada’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-38,010
| Closed | -$3.53M | – | 8278 |
|
|
2021
Q4 | $3.53M | Buy |
38,010
+8,836
| +30% | +$582K | ﹤0.01% | 2648 |
|
|
2021
Q3 | $1.74M | Buy |
29,174
+8,005
| +38% | +$473K | ﹤0.01% | 3191 |
|
|
2021
Q2 | $1.44M | Sell |
21,169
-5,333
| -20% | -$348K | ﹤0.01% | 3343 |
|
|
2021
Q1 | $1.84M | Buy |
26,502
+2,051
| +8% | +$158K | ﹤0.01% | 3086 |
|
|
2020
Q4 | $1.88M | Sell |
24,451
-5,056
| -17% | -$379K | ﹤0.01% | 2974 |
|
|
2020
Q3 | $2.21M | Buy |
29,507
+19,203
| +186% | +$1.28M | ﹤0.01% | 2612 |
|
|
2020
Q2 | $648K | Buy |
10,304
+1,047
| +11% | +$57.6K | ﹤0.01% | 3552 |
|
|
2020
Q1 | $389K | Buy |
9,257
+4,504
| +95% | +$207K | ﹤0.01% | 3832 |
|
|
2019
Q4 | $216K | Buy |
4,753
+2,170
| +84% | +$103K | ﹤0.01% | 4590 |
|
|
2019
Q3 | $118K | Buy |
2,583
+963
| +59% | +$54.1K | ﹤0.01% | 4725 |
|
|
2019
Q2 | $95K | Buy |
1,620
+173
| +12% | +$8.94K | ﹤0.01% | 4913 |
|
|
2019
Q1 | $65K | Sell |
1,447
-385
| -21% | -$17.7K | ﹤0.01% | 5035 |
|
|
2018
Q4 | $71K | Sell |
1,832
-1,505
| -45% | -$59.1K | ﹤0.01% | 4917 |
|
|
2018
Q3 | $153K | Sell |
3,337
-13,046
| -80% | -$529K | ﹤0.01% | 4623 |
|
|
2018
Q2 | $714K | Buy |
16,383
+13,166
| +409% | +$566K | ﹤0.01% | 3497 |
|
|
2018
Q1 | $127K | Sell |
3,217
-393
| -11% | -$15.3K | ﹤0.01% | 4561 |
|
|
2017
Q4 | $122K | Sell |
3,610
-935
| -21% | -$26.6K | ﹤0.01% | 4700 |
|
|
2017
Q3 | $116K | Buy |
4,545
+4,325
| +1,966% | +$99.2K | ﹤0.01% | 4907 |
|
|
2017
Q2 | $4K | Sell |
220
-1,673
| -88% | -$22.9K | ﹤0.01% | 6142 |
|
|
2017
Q1 | $28K | Buy |
1,893
+83
| +5% | +$1.23K | ﹤0.01% | 5464 |
|
|
2016
Q4 | $26K | Buy |
1,810
+1,421
| +365% | +$22K | ﹤0.01% | 5629 |
|
|
2016
Q3 | $7K | Buy |
389
+105
| +37% | +$1.74K | ﹤0.01% | 5897 |
|
|
2016
Q2 | $5K | Buy |
284
+74
| +35% | +$1.32K | ﹤0.01% | 5964 |
|
|
2016
Q1 | $4K | Sell |
210
-8,868
| -98% | -$142K | ﹤0.01% | 5995 |
|
|
2015
Q4 | $172K | Buy |
9,078
+7,689
| +554% | +$157K | ﹤0.01% | 4626 |
|
|
2015
Q3 | $27K | Buy |
1,389
+629
| +83% | +$21.4K | ﹤0.01% | 5443 |
|
|
2015
Q2 | $35K | Sell |
760
-950
| -56% | -$41.2K | ﹤0.01% | 5415 |
|
|
2015
Q1 | $75K | Sell |
1,710
-434
| -20% | -$20.2K | ﹤0.01% | 4764 |
|
|
2014
Q4 | $74K | Buy |
2,144
+1,817
| +556% | +$73.8K | ﹤0.01% | 4870 |
|
|
2014
Q3 | $14K | Sell |
327
-229
| -41% | -$10.2K | ﹤0.01% | 5388 |
|
|
2014
Q2 | $33K | Buy |
556
+17
| +3% | +$1.07K | ﹤0.01% | 5033 |
|
|
2014
Q1 | $34K | Sell |
539
-3,804
| -88% | -$252K | ﹤0.01% | 5017 |
|
|
2013
Q4 | $254K | Sell |
4,343
-7,349
| -63% | -$384K | ﹤0.01% | 3974 |
|
|
2013
Q3 | $616K | Buy |
11,692
+10,381
| +792% | +$697K | ﹤0.01% | 3209 |
|
|
2013
Q2 | $101K | Buy |
+1,311
| New | +$107K | ﹤0.01% | 4304 |
|
Royal Bank of Canada's ARNA Position: Q1 2022 in Review
Royal Bank of Canada sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 38,010 shares — an estimated $3.53M sold.
Royal Bank of Canada first reported a position in ARNA in Q2 2013 and held it in 35 quarters. The position peaked at $3.53M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.
- Royal Bank of Canada reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- Royal Bank of Canada sold 38,010 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $3.53M.
- Royal Bank of Canada first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 35 quarters.
- Royal Bank of Canada's Arena Pharmaceuticals Inc position peaked at $3.53M in Q4 2021.
- 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.
Based on Royal Bank of Canada's 13F filing for Q1 2022, filed 16 May 2022.